Join to access to all OVN content. Join for Free
Never Split the Difference
Medical Science Liaison tactical empathy active listening calibrated questions 7-38-55 rule

Never Split the Difference


Share This Article


Summary

In this weeks episode, Linda Traylor, VP, Head of Medical Excellence at Acceleration Point and Josh Yoder, Sr Medical Science Liaison at Aurinia, discuss the book, Never Split the Difference by Chris Voss, a MUST read for MSLs and Medical Affairs Professionals.

Learn more about…

πŸ‘‰ How to use tactical empathy and active listening
πŸ‘‰ What is mirroring and how can it be used in field medical?
πŸ‘‰ How to use labeling, also called naming
πŸ‘‰ What are calibrated questions and how can MSLs use them
πŸ‘‰ What is the 7-38-55 rule and why is it so important

Click for Source
Medical Science Liaison, tactical empathy, active listening, calibrated questions, 7-38-55 rule

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Social Media Listening Evolved
Partner Avatar MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson

Social Media Listening Evolved

Podcast
Over-Negotiation-How to Botch a Job Offer
Partner Avatar MSL Talk: Tom Caravela

Over-Negotiation-How to Botch a Job Offer

Article
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
OVN Avatar Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH

Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions

Article
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
OVN Avatar Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, GaΓ«lle Guyaderb, Lotfi Boudalib, Nicolas Albin

Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years

Article
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
OVN Avatar Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS

Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review

Article
Transforming oncology: Five frontiers driving progress in cancer care
Partner Avatar iNIZIO

Transforming oncology: Five frontiers driving progress in cancer care

Explore OVN